OstomyCure
Private Company
Funding information not available
Overview
OstomySecure is a clinical-stage medical device innovator focused on transforming care for ostomy patients. Its flagship product, the TIES® System, is a three-component implantable device that aims to provide a continent, controlled stoma management solution, eliminating the need for a permanent external pouch. The technology is currently under clinical investigation across multiple European countries and India, positioning the company to address a significant unmet need in the global stoma care market. OstomySecure operates as a private, pre-revenue entity, advancing its platform through clinical trials.
Technology Platform
The TIES® (Transcutaneous Implant Evacuation System) is a three-component implantable medical device platform. It consists of a surgically implanted abdominal port that integrates with tissue, a removable external sealing lid, and a dedicated emptying pouch. The platform enables controlled, continent stoma management without a permanent external ostomy bag.
Opportunities
Risk Factors
Competitive Landscape
Primary competition comes from large, entrenched manufacturers of traditional ostomy pouches and accessories (e.g., Coloplast, ConvaTec, Hollister). The TIES System is a disruptive, implant-based technology that does not have a direct equivalent, but incumbents have significant resources to develop or acquire competing solutions if the market validates the approach.